Norsko -
norština -
Statens legemiddelverk
solifenacin sandoz 10 mg
sandoz - københavn - solifenacinsuksinat - tablett, filmdrasjert - 10 mg
Norsko -
norština -
Statens legemiddelverk
solifenacin sandoz 5 mg
sandoz - københavn - solifenacinsuksinat - tablett, filmdrasjert - 5 mg
Norsko -
norština -
Statens legemiddelverk
atorvastatin hexal 40 mg
hexal a/s - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 40 mg
Norsko -
norština -
Statens legemiddelverk
atorvastatin hexal 10 mg
hexal a/s - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 10 mg
Norsko -
norština -
Statens legemiddelverk
atorvastatin hexal 20 mg
hexal a/s - atorvastatinkalsiumtrihydrat - tablett, filmdrasjert - 20 mg
Evropská unie -
norština -
EMA (European Medicines Agency)
tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - karsinom, ikke-småcellet lunge - antineoplastiske midler - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.
Norsko -
norština -
Statens legemiddelverk
sitagliptin/metformin sandoz 50 mg / 1000 mg
sandoz - københavn - sitagliptinhydrokloridmonohydrat / metforminhydroklorid - tablett, filmdrasjert - 50 mg / 1000 mg
Norsko -
norština -
Statens legemiddelverk
sitagliptin/metformin sandoz 50 mg / 850 mg
sandoz - københavn - sitagliptinhydrokloridmonohydrat / metforminhydroklorid - tablett, filmdrasjert - 50 mg / 850 mg
Norsko -
norština -
Statens legemiddelverk
sitagliptin sandoz 25 mg
sandoz - københavn - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 25 mg
Norsko -
norština -
Statens legemiddelverk
sitagliptin sandoz 50 mg
sandoz - københavn - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 50 mg